Effect of Obstructive Sleep Apnea during Pregnancy on Fetal Development: Gene Expression Profile of Cord Blood.

cord blood fetal development gene expression hypoxia obstructive sleep apnea (OSA) oxidative stress perinatal outcomes pregnancy qPCR rapid eye movement (REM) sleep

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 May 2024
Historique:
received: 29 04 2024
revised: 15 05 2024
accepted: 16 05 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Obstructive sleep apnea (OSA) is quite prevalent during pregnancy and is associated with adverse perinatal outcomes, but its potential influence on fetal development remains unclear. This study investigated maternal OSA impact on the fetus by analyzing gene expression profiles in whole cord blood (WCB). Ten women in the third trimester of pregnancy were included, five OSA and five non-OSA cases. WCB RNA expression was analyzed by microarray technology to identify differentially expressed genes (DEGs) under OSA conditions. After data normalization, 3238 genes showed significant differential expression under OSA conditions, with 2690 upregulated genes and 548 downregulated genes. Functional enrichment was conducted using gene set enrichment analysis (GSEA) applied to Gene Ontology annotations. Key biological processes involved in OSA were identified, including response to oxidative stress and hypoxia, apoptosis, insulin response and secretion, and placental development. Moreover, DEGs were confirmed through qPCR analyses in additional WCB samples (7 with OSA and 13 without OSA). This highlighted differential expression of several genes in OSA (

Identifiants

pubmed: 38791576
pii: ijms25105537
doi: 10.3390/ijms25105537
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : SEPAR-2020-820, Ministerio de Economia y Competitividad
ID : PI11/00495
Organisme : Ministerio de Ciencia, Innovación y Universidades
ID : PI19/00875

Auteurs

Laura Cànaves-Gómez (L)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.

Aarne Fleischer (A)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Genomic & Bioinformatics Platform, IdISBa, 07120 Palma de Mallorca, Spain.

Josep Muncunill-Farreny (J)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Genomic & Bioinformatics Platform, IdISBa, 07120 Palma de Mallorca, Spain.

María Paloma Gimenez (MP)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.

Ainhoa Álvarez Ruiz De Larrinaga (A)

Hospital Universitario de Araba, 01009 Vitoria-Gasteiz, Spain.
Departamento de Neurociencias, Instituto de Investigación Sanitaria Bioaraba, 01009 Vitoria-Gasteiz, Spain.

Andrés Sánchez Baron (A)

Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain.

Mercedes Codina Marcet (M)

Servicio de Endocrinología, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.

Mónica De-La-Peña (M)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Servicio de Neumología, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.
Facultad de Medicina, Universidad de las Islas Baleares, 07122 Palma de Mallorca, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III (CIBERES), 28029 Madrid, Spain.

Daniel Morell-Garcia (D)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Servicio de Análisis Clínicos, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.

José Peña Zarza (J)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Servicio de Pediatría, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.

Concepción Piñas Zebrian (C)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Servicio de Neumología, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.

Susana García Fernández (S)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Servicio de Neumología, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.

Alberto Alonso (A)

Instituto de Investigación Sanitaria Illes Balears (IdISBa), 07120 Palma de Mallorca, Spain.
Servicio de Neumología, Hospital Universitari Son Espases, 07120 Palma de Mallorca, Spain.
Facultad de Medicina, Universidad de las Islas Baleares, 07122 Palma de Mallorca, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III (CIBERES), 28029 Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH